高强度聚焦超音波 (HIFU) 市场机会、成长动力、产业趋势分析及 2025-2034 年预测

2024 年全球高强度聚焦超音波市场规模达到 6.84 亿美元，预计 2025 年至 2034 年期间的复合年增长率为 10.4%。随着越来越多的医疗保健提供者和患者认识到 HIFU 技术在无需侵入性手术的情况下治疗各种疾病的有效性，对 HIFU 技术的需求正在迅速增长。作为一种非侵入性疗法，HIFU 已获得 FDA 批准，可用于治疗多种慢性疾病，包括肿瘤和特发性震颤。该技术利用聚焦超音波能量精确瞄准受影响的组织，最大限度地减少对周围区域的损害。与传统外科手术不同，HIFU 的恢復时间更快、疼痛减轻、治疗后併发症更少，因此成为患者和医疗保健专业人员的首选。

影像技术和即时监控的进步进一步提高了HIFU治疗的疗效和安全性，推动了其在各个医疗领域的应用。人们对非侵入性治疗方案的认识不断提高，以及癌症、子宫肌瘤和神经系统疾病等疾病的盛行率不断上升，继续推动市场扩张。此外，向门诊护理和微创治疗的转变正在重塑医疗保健行业，进一步将 HIFU 定位为现代医学的游戏规则改变者。随着对经济高效、低风险治疗方案的需求激增，研发方面的投资正在推动更先进的 HIFU 设备的推出。市场参与者正在积极与医疗机构合作，以加速产品创新并扩大其全球影响力，确保 HIFU 技术在已开发经济体和新兴经济体中广泛应用。

市场按应用细分，主要治疗领域包括皮肤科、子宫肌瘤、摄护腺癌、乳癌、青光眼、背痛和特发性震颤。 2024 年，皮肤病学将成为领先的细分市场，由于非侵入性美容手术的日益普及，皮肤病学将产生可观的收入。由于 HIFU 能够刺激胶原蛋白的产生并增强皮肤弹性，使其成为传统美容手术的热门替代品，因此面部拉皮、减少皱纹和紧緻皮肤等治疗方法越来越受到人们的欢迎。由于没有停机时间且效果持久，HIFU 在美容和保健领域继续受到关注，进一步推动市场成长。

按最终用户划分，医院在 2024 年占据 42.8% 的市场份额，在 HIFU 领域占据主导地位。作为综合医疗保健的主要提供者，医院正在将 HIFU 整合到各种疾病的治疗方案中。 FDA 和 CE 等机构的监管批准加强了医院的采用，而对医疗保健基础设施的投资不断增加也继续加强了这一领域。 HIFU 能够满足包括儿童和成人在内的不同患者群体的需求，这进一步推动了其在医院环境中的应用。

美国高强度聚焦超音波 (HIFU) 市场在 2023 年创造了 2.239 亿美元的产值，预计到 2034 年将达到 6.045 亿美元。该国先进的医疗保健体系，加上前列腺癌的高发病率，正在推动 HIFU 的广泛应用。强有力的监管框架、不断增加的医疗创新投资以及对非侵入性治疗方案的认识不断提高，都促进了市场扩张。随着技术进步不断提高 HIFU 的有效性和可近性，美国将继续在全球 HIFU 领域发挥关键作用。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 慢性病发生率上升
    • 增加监管批准和报销政策
    • 非侵入性疗法日益受到青睐
    • 扩大在非癌症疾病的应用
  • 产业陷阱与挑战
    • 设备和手术成本高昂
• 成长潜力分析
• 监管格局
• 技术格局
• 未来市场趋势
• 差距分析
• 波特的分析
• PESTEL 分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：按应用，2021 年至 2034 年

• 主要趋势
• 子宫肌瘤
• 摄护腺癌
• 特发性震颤
• 皮肤科
• 乳癌
• 青光眼
• 背痛
• 其他应用

第六章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 医院
• 影像中心
• 其他最终用途

第七章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋

第八章：公司简介

• ALPINION MEDICAL SYSTEMS
• Arrayus Technologies
• Chongqing Haifu Medical Technology
• Focal One
• FUSMobile
• Insightec
• Lynton Lasers
• Profound Medical
• Sonablate
• Theraclion
• ULTRAISER
• Verasonics

The Global High Intensity Focused Ultrasound Market reached USD 684 million in 2024 and is projected to grow at a CAGR of 10.4% between 2025 and 2034. The demand for HIFU technology is rising rapidly as more healthcare providers and patients recognize its effectiveness in treating various medical conditions without the need for invasive surgery. As a non-invasive therapy, HIFU has gained FDA approval for treating several chronic conditions, including tumors and essential tremors. The technology utilizes focused ultrasound energy to target affected tissues with precision, minimizing damage to surrounding areas. Unlike traditional surgical procedures, HIFU offers faster recovery times, reduced pain, and fewer post-treatment complications, making it a preferred choice for patients and healthcare professionals alike.

Advancements in imaging technology and real-time monitoring have further enhanced the efficacy and safety of HIFU treatments, driving its adoption across diverse medical fields. Increasing awareness of non-invasive therapeutic solutions and the rising prevalence of conditions such as cancer, fibroids, and neurological disorders continue to fuel market expansion. Additionally, the shift toward outpatient care and minimally invasive treatments is reshaping the healthcare industry, further positioning HIFU as a game-changer in modern medicine. As demand for cost-effective, low-risk treatment alternatives surges, investments in research and development are leading to the introduction of more sophisticated HIFU devices. Market players are actively collaborating with healthcare institutions to accelerate product innovation and expand their global footprint, ensuring widespread accessibility of HIFU technology in both developed and emerging economies.

The market is segmented by application, with key treatment areas including dermatology, uterine fibroids, prostate cancer, breast cancer, glaucoma, back pain, and essential tremors. In 2024, dermatology emerged as the leading segment, generating substantial revenue due to the rising popularity of non-invasive aesthetic procedures. Treatments such as facelifts, wrinkle reduction, and skin tightening have witnessed increased adoption, as HIFU's ability to stimulate collagen production and enhance skin elasticity makes it a sought-after alternative to traditional cosmetic procedures. With no downtime and long-lasting results, HIFU continues to gain traction in the beauty and wellness sector, further propelling market growth.

By end-user, hospitals accounted for a 42.8% market share in 2024, dominating the HIFU landscape. As key providers of comprehensive medical care, hospitals are integrating HIFU into treatment protocols for a wide range of conditions. Regulatory approvals from bodies like the FDA and CE have reinforced hospital adoption while increasing investments in healthcare infrastructure continue to strengthen this segment. The ability of HIFU to cater to diverse patient demographics, including children and adults, is further driving its use in hospital settings.

The U.S. High Intensity Focused Ultrasound (HIFU) Market generated USD 223.9 million in 2023 and is expected to reach USD 604.5 million by 2034. The country's advanced healthcare system, coupled with a high incidence of prostate cancer, is driving the widespread adoption of HIFU. The presence of a strong regulatory framework, increasing investment in healthcare innovation, and growing awareness of non-invasive treatment options are contributing to market expansion. As technological advancements continue to enhance the effectiveness and accessibility of HIFU, the U.S. is poised to remain a key player in the global HIFU landscape.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising incidence of chronic diseases
    • 3.2.1.2 Increasing regulatory approvals and reimbursement policies
    • 3.2.1.3 Increasing preference for non-invasive therapies
    • 3.2.1.4 Expanding applications in non-cancer diseases
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of equipment and procedures
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter’s analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Uterine fibroids
• 5.3 Prostate cancer
• 5.4 Essential tremor
• 5.5 Dermatology
• 5.6 Breast cancer
• 5.7 Glaucoma
• 5.8 Backpain
• 5.9 Other applications

Chapter 6 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Hospitals
• 6.3 Imaging centers
• 6.4 Other End Use

Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 India
  • 7.4.3 Japan
  • 7.4.4 Australia
  • 7.4.5 South Korea
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 Middle East and Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 South Africa
  • 7.6.3 UAE

Chapter 8 Company Profiles

• 8.1 ALPINION MEDICAL SYSTEMS
• 8.2 Arrayus Technologies
• 8.3 Chongqing Haifu Medical Technology
• 8.4 Focal One
• 8.5 FUSMobile
• 8.6 Insightec
• 8.7 Lynton Lasers
• 8.8 Profound Medical
• 8.9 Sonablate
• 8.10 Theraclion
• 8.11 ULTRAISER
• 8.12 Verasonics